Predictive modelling of COPD exacerbation rates using baseline risk factors
D. Singh (Manchester, United Kingdom), F. Martinez (New York, NY, United States of America), K. Rabe (Grosshansdorf, Germany), J. Hurst (London, United Kingdom), M. Bafadhel (Oxford, United Kingdom), M. Jenkins (Cambridge, United Kingdom), P. Dorinsky (Durham, NC, United States of America), P. Darken (Morristown, NJ, United States of America)
Source: Virtual Congress 2020 – Advances in pharmacological treatment of COPD
Session: Advances in pharmacological treatment of COPD
Session type: Oral Presentation
Number: 5235
Disease area: Airway diseases
Rating:
You must login to grade this presentation.
Share or cite this content
Citations should be made in the following way:
D. Singh (Manchester, United Kingdom), F. Martinez (New York, NY, United States of America), K. Rabe (Grosshansdorf, Germany), J. Hurst (London, United Kingdom), M. Bafadhel (Oxford, United Kingdom), M. Jenkins (Cambridge, United Kingdom), P. Dorinsky (Durham, NC, United States of America), P. Darken (Morristown, NJ, United States of America). Predictive modelling of COPD exacerbation rates using baseline risk factors. 5235
You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
Related content which might interest you:
Related content which might interest you: